slotkoers
Korea S.E.
00:00:00 03-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
3.570
KRW
|
0,00%
|
|
-5,56%
|
+15,53%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
150.365
|
191.246
|
219.226
|
327.966
|
242.875
|
Bedrijfswaarde
1 |
141.036
|
183.843
|
225.137
|
322.542
|
233.135
|
K/w-verhouding
|
33,1
x
|
23,2
x
|
22,7
x
|
-108
x
|
-1.445
x
|
Dividendrendement
|
-
|
0,6%
|
0,7%
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,27
x
|
3,27
x
|
3,4
x
|
3,8
x
|
4,6
x
|
Bedrijfswaarde/omzet
|
3,06
x
|
3,14
x
|
3,5
x
|
3,74
x
|
4,41
x
|
Bedrijfswaarde/EBITDA
|
19,3
x
|
20,2
x
|
18,7
x
|
34,3
x
|
102
x
|
Bedrijfswaarde/FCF
|
-100
x
|
73,7
x
|
-14,1
x
|
247
x
|
-397
x
|
FCF Yield
|
-1%
|
1,36%
|
-7,12%
|
0,41%
|
-0,25%
|
Price to Book
|
3,59
x
|
3,57
x
|
3,39
x
|
4,8
x
|
2,38
x
|
Aantal aandelen (in duizenden)
|
65.853
|
68.574
|
68.867
|
70.530
|
78.600
|
Referentieprijs
2 |
2.283
|
2.789
|
3.183
|
4.650
|
3.090
|
Datum van publicatie
|
19/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
46.040
|
58.520
|
64.403
|
86.277
|
52.814
|
EBITDA
1 |
7.303
|
9.095
|
12.033
|
9.412
|
2.290
|
Bedrijfsresultaat (EBIT)
1 |
5.873
|
7.040
|
9.007
|
5.309
|
-1.186
|
Operationele Marge
|
12,76%
|
12,03%
|
13,99%
|
6,15%
|
-2,25%
|
Resultaat voor belastingen (EBT)
1 |
5.375
|
9.471
|
12.827
|
-2.345
|
325,7
|
Nettowinst (verlies)
1 |
4.195
|
8.302
|
11.031
|
-2.995
|
-164
|
Nettomarge
|
9,11%
|
14,19%
|
17,13%
|
-3,47%
|
-0,31%
|
WPA
2 |
69,00
|
120,2
|
140,1
|
-43,00
|
-2,138
|
Free Cash Flow
1 |
-1.410
|
2.495
|
-16.022
|
1.307
|
-586,8
|
FCF-marge
|
-3,06%
|
4,26%
|
-24,88%
|
1,51%
|
-1,11%
|
Kasstroomconversie (ebitda)
|
-
|
27,44%
|
-
|
13,88%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
30,06%
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
16,67
|
22,22
|
-
|
-
|
Datum van publicatie
|
19/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
5.911
|
-
|
-
|
Nettokaspositie
1 |
9.329
|
7.404
|
-
|
5.424
|
9.740
|
Hefboom (schuld/ebitda)
|
-
|
-
|
0,4912
x
|
-
|
-
|
Free Cash Flow
1 |
-1.410
|
2.495
|
-16.022
|
1.307
|
-587
|
ROE (netto-inkomsten/eigen vermogen)
|
13,8%
|
17,3%
|
19%
|
-4,2%
|
-0,06%
|
ROA (netto-inkomsten/totale activa)
|
6,97%
|
6,48%
|
6,67%
|
2,51%
|
-0,43%
|
Totale activa
1 |
60.162
|
128.066
|
165.420
|
-119.519
|
38.053
|
Nettoactief per aandeel
2 |
636,0
|
782,0
|
938,0
|
968,0
|
1.300
|
Cashflow per aandeel
2 |
79,00
|
117,0
|
89,40
|
211,0
|
881,0
|
Capex
1 |
5.547
|
3.947
|
19.598
|
4.894
|
4.002
|
Capex/omzet
|
12,05%
|
6,75%
|
30,43%
|
5,67%
|
7,58%
|
Datum van publicatie
|
19/03/20
|
22/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +15,53% | 227 mln. | | -16,10% | 11,41 mld. | | -30,20% | 2,3 mld. | | -14,31% | 2,16 mld. | | -26,03% | 1,56 mld. | | +36,95% | 1,19 mld. | | -2,40% | 760 mln. | | -19,00% | 506 mln. | | -38,57% | 444 mln. | | +13,72% | 339 mln. |
Bio-diagnostiek & testen
|